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Abstract
Electroconvulsive therapy (ECT) is an effective treatment for depression, but can have neg-
ative side effects including amnesia. The mechanisms of action underlying both the antide-
pressant and side effects of ECT are not well understood. An equivalent manipulation that is
conducted in experimental animals is electroconvulsive seizure (ECS). Rodent studies have
provided valuable insights into potential mechanisms underlying the antidepressant and
side effects of ECT. However, relatively few studies have investigated the effects of ECS in
animal models with a depression-relevant manipulation such as chronic stress. In the pres-
ent study, mice were first exposed to chronic social stress (CSS) or a control procedure for
15 days followed by ECS or a sham procedure for 10 days. Behavioral effects were investi-
gated using an auditory fear conditioning (learning) and expression (memory) test and a
treadmill-running fatigue test. Thereafter, immunohistochemistry was conducted on brain
material using the microglial marker Iba-1 and the cholinergic fibre marker ChAT. CSS did
not increase fear learning and memory in the present experimental design; in both the con-
trol and CSS mice ECS reduced fear learning and fear memory expression. CSS induced
the expected fatigue-like effect in the treadmill-running test; ECS induced increased fatigue
in CSS and control mice. In CSS and control mice ECS induced inflammation in hippocam-
pus in terms of increased expression of Iba-1 in radiatum of CA1 and CA3. CSS and ECS
both reduced acetylcholine function in hippocampus as indicated by decreased expression
of ChAT in several hippocampal sub-regions. Therefore, CSS increased fatigue and
reduced hippocampal ChAT activity and, rather than reversing these effects, a repeated
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ECS regimen resulted in impaired fear learning-memory, increased fatigue, increased hip-
pocampal Iba-1 expression, and decreased hippocampal ChAT expression. As such, the
current model does not provide insights into the mechanism of ECT antidepressant function
but does provide evidence for pathophysiological mechanisms that might contribute to
important ECT side-effects.
1. Introduction
Electroconvulsive therapy (ECT) is one of the most effective therapies for major depressive dis-
order (MDD) [1]. One of the main indications for ECT is treatment-resistant depression, in
which ECT reaches remission rates of around 50% [2]. In addition, due to its quick onset of
clinical improvement, ECT is applied for the prevention of suicide in severe depression [3].
ECT involves the induction of brain seizures via electrodes that are placed on the patient’s scalp.
ECT is typically given 2–3 times per week and clinical improvement is monitored closely. The
total number of treatments that are required to achieve full remission of depressive symptoms
varies between patients, with most patients achieving remission within four weeks after treat-
ment onset [4]. Whilst ECT has only a few adverse effects, cognitive deficits, primarily in the
form of anterograde and retrograde amnesia, are quite common and constitute a limitation on
the clinical applicability of ECT [5]. These cognitive ECT side effects are typically transient, sub-
siding within weeks to months after discontinuation of treatment, with more severe and persis-
tent cases of amnesia being relatively rare [5].
Despite its high efficacy as a depression treatment, the mechanisms by which ECT exerts its
beneficial effects remain poorly understood. Animal studies investigating the effects of electro-
convulsive seizures (ECS), the animal counterpart of ECT, offer unique opportunities to iden-
tify the mechanisms underlying the clinical effects and side effects of ECT. ECS experiments
are typically conducted in rat or mouse and take the form of inducing seizures by applying
electric current via ear clip electrodes. Studies differ in the number and frequency of ECS ses-
sions, with sessions usually being given daily or once per 2–3 days, and a total of 5–10 sessions
[6–8]. This variation is indicative of a lack of consensus on what might be an optimal ECS pro-
tocol in rodents.
To-date, the focus of rodent ECS experiments has been to study its impact on behavior and
brain in otherwise non-manipulated, “healthy” rodents. With regards to behavior, it has been
demonstrated, for example, that ECS induces increased mobility in the forced swim test, the
same effect as acute antidepressant administration [9–11]. With regards to the brain, notable
and consistent effects of ECS in rodents are increases in hippocampal neurogenesis [12,13]
and in the expression of neurotrophic factors including brain derived neurotrophic factor
(BDNF) and vascular endothelial growth factor (VEGF) [14–18]. These effects may indicate
rearrangement of the cellular connectivity between hippocampus and its afferent and efferent
projection areas [19,20]. In humans, ECT-induced neurogenesis and neurotrophic effects can
be inferred indirectly from the observed increases in hippocampal volume and in serum/
plasma levels of neurotrophic factors including BDNF and VEGF [14,21–25].
In order to increase the back-translational relevance of animal studies of ECS effects, it
needs to be applied in animal models of depression-relevant pathology. A small number of
such studies have been conducted, including the reversal by ECS of changes induced by
chronic unpredictable mild stress or repeated corticosterone administration, or of depression-
relevant traits induced by selected breeding e.g. Flinders Sensitive Line rat and Wistar-Kyoto
ECS induce behavioral and hippocampal changes relevant to side effects
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rat. For each of these models, ECS has been demonstrated to normalize behavior in one or
more behavioral tests, including the forced swim test, the sucrose preference test, and the open
field test [26–30].
These studies have provided valuable insights into the mechanisms underlying the antide-
pressant and side effects of ECT. For example, ECS-induced reductions in depression-like
behavior were found to be accompanied by normalization of BDNF and Neuropeptide Y
expression in brain areas relevant to depression [27–30]. Other studies have focused on the
mechanisms involved in ECS-induced memory impairment, with results pointing towards
increased HPA-axis activity and decreased long-term potentiation as underlying factors
[27,29]. Interestingly, memory-related side effects could be prevented by pre-treatment with
propofol without affecting antidepressant effects, provided that ECS stimulus intensity was
increased in propofol-treated rats, demonstrating the importance of performing ECS studies
under clinically relevant conditions [29].
In mice, environmental manipulations based on the resident-intruder paradigm have been
demonstrated to lead to depression-relevant changes in brain, physiology and behavior. In
chronic social stress (CSS), C57BL/6 mice are exposed continually to mice of a dominant,
aggressive strain, CD-1, including brief daily attacks, for 15 days. Relative to control mice, CSS
mice exhibit altered brain functional connectivity [31], increased immune-inflammation in
periphery and brain in terms of pro-inflammatory cytokines and the kynurenine pathway
[32,33], decreased motivation for reward [34], increased Pavlovian fear learning-memory
[32,33], increased learned helplessness [32], and increased physical fatigue [32]. It has been
demonstrated that some CSS-induced reward deficits are attenuated by the antidepressant
agomelatine [34], and that CSS-induced excessive fear memory is reversed by the antidepres-
sant escitalopram as well as by an inhibitor of the kynurenine pathway [33]. That is, CSS
induces changes in behavioral processes that are recognised as important dimensions in nega-
tive valence and positive valence domains in the research domain criteria (RDoC) framework
for mental disorders [35]. These CSS effects are obtained without dividing mice into suscepti-
ble versus unsusceptible sub-groups based on their subsequent passive avoidance of the aggres-
sor mouse strain, the method used with a 10-day chronic social defeat protocol [36]. That is,
CSS has been applied using an inclusive experimental design, as used extensively by other
groups with other stressors e.g. chronic unpredictable mild stress [37–39].
The principal aims of the current mouse study were to investigate the effects of ECS in
terms of reversing the depression-relevant behavioral changes induced by CSS and to establish
the concomitant changes in the hippocampus in terms of markers of microglia and acetylcho-
line function. The behavioral states of interest were, increases in fear learning-memory and
fatigue. Such a model would be valuable for the back-translational study of the neurobiology
underlying antidepressant effects and side effects of ECT.
Mice underwent CSS or control exposure, followed by 10 daily ECS or sham-control ses-
sions, and were then tested in terms of fear learning-memory and physical fatigue. Whilst the
expected CSS effect of increased fear learning-memory was not maintained in combination
with the ECS/sham procedure, the expected CSS effect of increased fatigue was observed but
was further increased, rather than being reversed, by ECS. Interestingly, however, repeated
ECS resulted in impaired learning-memory, which is of relevance to the cognitive side effects
that are a common feature of ECT. There is evidence that ECT/ECS-induced cognitive
impairment is associated with structural and functional alterations in the cholinergic system
[40,41]. There is also evidence that immune activation, including increased microglial activity,
is increased after ECS [6,42], which may in turn induce short-term cognitive deficits [43].
Therefore, to investigate their involvement in the ECS-induced cognitive impairments
observed in this study, we assessed hippocampal tissue for changes in immunohistochemical
ECS induce behavioral and hippocampal changes relevant to side effects
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markers of these two systems: the microglial marker ionized calcium-binding adapter mole-
cule (Iba-1) and the cholinergic marker choline acetyl transferase (ChAT). ECS increased
microglial activity and decreased ChAT activity in the hippocampus of CSS and control mice,
thus supporting a role for cholinergic alterations and neuroimmune activation in ECT/ECS-
induced cognitive deficits.
2. Materials & methods
2.1. Animals
C57BL/6J male mice were bred in-house (Zu¨rich), weaned at 3 weeks and housed in groups of
2–3 littermates up to the start of the experiment, at age 10 weeks. The CD-1 mice used for CSS
were ex-breeder males aged 8 months obtained from Janvier (France), and single-housed up to
the start of the experiment. Mice were kept in IVC cages on a reversed 12:12 light/dark cycle
(lights off at 7 am), and at 20–22˚C and 50–60% humidity. Food and water were available ad
libitum. Mice were handled daily for 5 days before the start of the experiment. Measurement of
body weight was performed daily for the entire duration of the experiment. As described
below, mice were allocated to CSS or control by counterbalancing on their motor activity
scores, followed by ECS or sham-procedure, yielding four treatment groups with n = 11–12
per group (CSSxSham and CSSxECS groups: n = 11, 11; CxSham and CxECS groups: n = 12,
12). The study was conducted under a permit (170/2012) issued by the Veterinary Office,
Zu¨rich, Switzerland.
2.2. Chronic social stress
Chronic social stress (CSS) was conducted as described in detail elsewhere [32]. Briefly, on the
first day of CSS (study day 1), each CSS mouse was housed singly in the home cage of a CD-1
mouse separated by a transparent, perforated divider. The CSS mouse was then placed with
the CD-1 mouse for either a cumulative total of 60 s physical attack or 10 min maximum. Each
day for 15 days, between 12 and 4 pm, the CSS x CD-1 mouse pairings were rotated so that
CSS mice were confronted daily with a novel CD-1 mouse; the CSS mouse remained in the
compartment where the confrontation occurred while the CD-1 mouse was placed in the
other compartment of its cage. To avoid bite wounds, the lower incisors of CD-1 mice were
trimmed every third day across CSS. Control mice remained in littermate pairs and were han-
dled and weighed daily.
2.3. Electroconvulsive seizures
Beginning on the day after 15-day CSS/control, half of the CSS and control mice received one
daily electroconvulsive seizure (ECS) over a period of 10 days (study days 16–25). Between 3
and 5 pm, mice were anesthetized with isoflurane (3% in O2 at 800 ml/min) and the ears were
cleaned with 70% alcohol. An electrical current of 80 mC (80 mA, 50 Hz, 1s duration and 0.5
ms pulse width) generated by an ECT unit (Ugo Basile, Italy) was applied via ear clip elec-
trodes. This current induced a tonic-clonic seizure lasting 5–20 seconds, with an overall aver-
age seizure duration (± SD) of 13.0 ± 2.2 seconds (12.9 ± 2.2 for the control group and
13.1 ± 2.2 for the CSS group) Averages of individual mice over all 10 ECS sessions ranged
from 11.1 to 14.5 seconds, which was comparable to seizure duration induced by ECS in other
studies [42,44,45]. The other half of the mice underwent a sham procedure comprising anaes-
thesia, ear cleaning and electrode attachment in the absence of ECS.
ECS induce behavioral and hippocampal changes relevant to side effects
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2.4. Behavioral testing
2.4.1. Motor activity test. Two motor activity tests were performed, the first prior to the
onset of CSS (morning of study day 1) and the second on the day after the last CSS session
(morning of study day 16). Using a Multi-Conditioning System (TSE Systems GmbH, Bad-
Homburg, Germany [46]), the mouse was placed in an arena containing a grid floor. The dis-
tance the mouse moved and the percentage of time spent freezing were recorded via an infra-
red beam movement detection system. The first test provided baseline activity scores that were
used to counterbalance allocation of mice to CSS and control groups [32]. The second test was
used to assess CSS effects on motor activity, in particular whether there was any evidence for
psychomotor retardation.
2.4.2. Tone-shock fear learning and memory. Increased responsiveness to acute threat,
including increased fear conditioning, is a common dimension in depression and other stress-
related psychiatric disorders [35,47], and CSS increases tone-shock fear learning and memory
[32,33]. Fear conditioning and expression testing [33,48] were conducted on two consecutive
days, starting the day after the last ECS session (study day 26). For fear conditioning, the mouse
was placed in the same arena as was used for the motor activity tests and exposed to six trials of a
discrete, neutral tone of 5 kHz at 85 dB (conditioned stimulus, CS) presented via a loudspeaker
for 20 sec. The final 2 sec were contiguous with a 2 sec x 0.15 mA inescapable foot shock (uncon-
ditioned stimulus, US) from the electrified grid floor. The inter-trial interval (ITI) was 120 s. For
analysis, trials were grouped in CS blocks 1–2, 3–4, 5–6 and ITIs 1, 2–3, 4–5. The following day,
for fear expression (memory) testing, the mouse was placed in the same arena and exposed to
nine trials of the tone CS for 30 sec and with an ITI of 90 sec, in the absence of foot shocks. For
analysis, trials were grouped into CS blocks 1–3, 4–6, 7–9, and ITIs 1–2, 3–5, 6–8. During each
session, percentage of time spent freezing was recorded during the CS and ITI.
2.4.3. Treadmill fatigue test. The treadmill fatigue test requires the mouse to run on an
inclined treadmill to avoid or escape an electrified floor at the base of the treadmill [32,49]. Fatigue
is a common symptom in depression (DSM-5, ICD-10). Reduced treadmill running is induced by
CSS [32] and by depletion of dopamine in the nucleus accumbens [34]. In contrast to the forced
swim test and tail suspension test, where it is unclear whether passivity indicates an adaptive,
energy-conserving strategy or a cessation of active coping [50], in the treadmill fatigue test it is
clear that passivity is maladaptive and related to fatigue. On two days after the fear expression test
(study days 28–29), mice were studied in a treadmill fatigue test [32], conducted using a mouse
single lane treadmill (Panlab/Harvard Apparatus, Cornellà, Spain) inclined at 5˚ with an electri-
fied grid (0.15 mA) at its lower end, which mice could avoid or escape by running uphill. On the
first day, the habituation session consisted of 2 min at a treadmill speed of 0 cm/sec, 5 min at 15–
20 cm/sec at 1 min increments, and 5 min at 20 cm/sec. The following day, first a warm-up test
was performed, consisting of 2 min at 0 cm/sec and 5 min at 20 cm/sec. Immediately afterwards,
a test session was conducted at a treadmill speed of 23 cm/sec. The total number and duration of
shocks the mouse received were scored automatically. For the test session the maximum duration
was 20 min (1200 sec); if a mouse reached a total cumulative duration of 10 sec foot shock, the test
was stopped immediately and the test duration up to this point was scored.
2.4.4. Hot plate test. In a subset of mice (n = 6 per group) a hot plate test [32,46] was con-
ducted immediately after the treadmill fatigue test, in order to assess whether group differences
were related to differences in nociception. The mouse was placed on a plate with a temperature
of 50˚C. The latency (sec) until the display of one of several pain-related behaviors (licking a
forepaw, licking a hind paw, lifting a hind paw or jumping) was scored, after which the mouse
was immediately removed from the hot plate and replaced in its home cage. The maximum
duration of the test was 60 seconds.
ECS induce behavioral and hippocampal changes relevant to side effects
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2.5. Immunohistochemistry
At 1 day after completion of behavioral testing (study day 30), mice were deeply anesthetized
(Pentobarbital) and perfused transcardially with 0.1M phosphate buffered saline (PBS) fol-
lowed by a 4% paraformaldehyde (PFA) solution in 0.1M phosphate buffer. The brain was
postfixed for 24 hours in 4% PFA in 0.1M PBS, followed by 18 hours in 0.1M PBS containing
30% sucrose. Brains were snap frozen on dry ice, temporarily stored at -80˚C, and cut into sec-
tions of 20 μm.
2.5.1. Ionized calcium-binding adaptor molecule 1 (Iba-1). The microglial marker Iba-1
was visualized by a 3,3’-diaminobenzidine (DAB) staining. Coronal sections were selected for
the following areas: prefrontal cortex (PFC), dorsal hippocampus, and ventral tegmental area
(VTA). Sections were incubated for 72 hours with a 1:2500 dilution of primary antibody (rab-
bit anti-Iba1, Wako Chemicals, Neuss, Germany) in 0.01M PBS (pH 7.4) containing 1% bovine
serum albumin (BSA) and 0.1% tritonX-100, followed by a 2-hour incubation with a 1:500
dilution of secondary antibody (goat anti-rabbit, Jackson ImmunoResearch, Suffolk, UK) in
0.01M PBS. Subsequently, sections were incubated for 1 hour with avidin-biotin complex
(1:500; Vector Laboratories Burlingame, CA, USA) in 0.01M PBS. Finally, 0.075 mg/mL DAB
was added and the DAB reaction was initiated with 100 μl 0.1% H2O2. After each step of the
protocol, sections were rinsed with 0.01M PBS.
Analysis of microglial activation was performed with Image Pro software (Image-Pro Plus
6.0.0.26, Media Cybernetics Inc., Rockville, USA) using a method described by Hovens et al.
[51]. Briefly, the software was used to determine the percentage of area covered by microglia
cells (“total microglial cell size”) and the percentage of area covered by microglial cell bodies
(“total size of the microglial cell bodies”). The ratio total size of the microglial cell bodies: total
microglial cell size (cb/c) reflects activation state in such a way that higher values reflect
increased microglial activity [51]. An investigator blinded to group assignment performed all
analyses.
2.5.2. Choline acetyltransferase (ChAT). An immunohistochemical staining for choline
acetyltransferase (ChAT) was performed to quantify cholinergic fiber density in hippocampal
areas. Free-floating hippocampal sections were pre-incubated for one hour in 0.01M PBS con-
taining 5% normal rabbit serum (NRS) and 0.4% Triton X-100 before incubation for 72 hours
with a 1:333 dilution of goat anti-ChAT primary antibody (Merck Millipore, Amsterdam,
Netherlands). This was followed by a 24-hour incubation with secondary antibody (rabbit
anti-goat, Jackson ImmunoResearch, Suffolk, UK) in PBS containing 1% NRS, 0.5% BSA, and
0.2% Triton X-100. Subsequently, sections were incubated for 1 hour with avidin-biotin com-
plex (1:500; Vector Laboratories Burlingame, CA, USA) in 0.01M PBS containing 0.2% Tri-
tonX-100. The DAB reaction was initiated by addition of 100 μl 0.1% H2O2 to a 0.075 mg/mL
DAB solution containing 0.5 mg/ml ammonium nickel sulphate. After each step, sections were
rinsed thoroughly with 0.01M PBS. Images were visualized using a microscope (Leica Micro-
systems, Rijswijk, Netherlands) at 400x magnification. Leica Application Suite (LAS) micro-
scope software (Leica Microsystems, Rijswijk, Netherlands) was used to quantify the
percentage of area covered by cholinergic fibers (fiber density). An investigator blinded to
group assignment performed all analyses.
2.6. Statistical analysis
The basic statistical model used was 2 groups (CSS, Control) x 2 treatments (ECS, Sham). Sta-
tistical analysis was conducted using either GraphPad Prism 5.0 (GraphPad Software, San
Diego, California, USA) or, in the case of 2- and 3-way repeated measure ANOVA, StatSoft
Statistica 8.0. Significant interaction effects were analysed using a Bonferroni post hoc test.
ECS induce behavioral and hippocampal changes relevant to side effects
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Statistical significance was set at p 0.05. All graphs were created in GraphPad Prism 5.0,
using mean ± sem.
3. Results
3.1. Effects of CSS and ECS on body weight
The duration of daily CSS attack time was 52.1 ± 0.9 sec (mean ± sem), with a minimum of 30
sec and a maximum of 60 sec per session. A minority (n = 5) of 22 CSS mice were observed to
fight back during 1–4 of the first 4 days of the protocol, and on days 5–15 all CSS mice dis-
played only submissive behavior during each session. Absolute body weight was measured
daily and averaged over blocks of five days, with block 1 covering the period prior to CSS, and
blocks 2, 3 and 4 covering the 15-day CSS protocol. There was a significant group X time inter-
action effect (p = 0.02), albeit in the absence of a group effect in any block (Fig 1A, S1 Table).
For absolute day-to-day body weight variability (% ΔBW; % body weight change across two
consecutive days, averaged over five days), there was a group x time interaction (p = 0.0001):
absolute ΔBW was increased in CSS compared to control mice in block 2 and 4 (Fig 1B, S1
Table). Increased percentage daily absolute ΔBW, which reflects daily body weight change
Fig 1. Comparison of body weight in CSS (n = 22) and control (n = 22) mice prior to and during ECS. A: Average body weight (g) in
5-day blocks prior to (block 1) and throughout the 15-day CSS procedure (block 2–4). B: Percentage average daily absolute (increase or
decrease) body weight delta during the same period. (C): Average body weight during the final 5 days of CSS (block 4) and throughout the
10-day ECS procedure (block 5–6). Data presented as mean + sem. *p<0.05; ***p<0.001; two-way ANOVA with Bonferroni post hoc test.
https://doi.org/10.1371/journal.pone.0184603.g001
ECS induce behavioral and hippocampal changes relevant to side effects
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regardless of whether it is an increase or decrease, provides a reproducible marker for CSS effi-
cacy [31–33].
To assess for group x treatment x time effects on average body weight, block 4 and two
blocks covering the 10-day ECS protocol were analysed (Fig 1C, S1 Table). In the absence of a
3-way interaction effect, there was a group x time interaction (p = 0.003) and a treatment x
time interaction (p<0.0001); however, post hoc tests did not reveal any block-specific signifi-
cant effects of either group or treatment.
3.2. CSS without effect and ECS decreases fear learning and memory
In the activity test conducted on study day 16, there was no difference in locomotor distance
between CSS (78980±6932 arbitrary units (a.u.)) and control (83430±5944 a.u.) mice
(p = 0.63). Following the 10-day ECS/sham treatments, tests of CS-US fear conditioning
(study day 26) and CS fear expression (day 27) were conducted, with % time spent freezing
used to quantify fear learning-memory. In contrast to previous CSS studies [32,33], there was
no effect of CSS on fear conditioning (p = 0.26 and p = 0,41 for freezing during ITIs and CS
respectively) or expression (p = 0,62 and p = 0,74 for freezing during ITIs and CS respectively).
At fear conditioning, during the ITIs between CS-US pairings (Fig 2A, S2 Table) there was a
treatment x trial interaction (p = 0.03); ECS mice exhibited less freezing than sham mice at ITI
1 and 2–3. During the CS of CS-US trials (Fig 2B, S2 Table) there was a main effect of trial
(p = 0.03) with freezing increasing across trials, and a main effect of treatment (p = 0.01) with
ECS mice exhibiting less conditioned freezing than sham mice. At fear expression, during ITIs
between CS trials (Fig 2C, S2 Table) and during CS trials (Fig 2D, S2 Table) there was a main
effect of treatment (p<0.0001 for ITI and CS) with ECS mice expressing less freezing than
sham mice.
3.3. Both CSS and ECS decrease running in the treadmill fatigue test
Both CSS and ECS attenuated running in the treadmill fatigue test. At the habituation phase
(study day 28, Fig 3A, S3 Table), there was no CSS effect, whilst the total duration of foot
shock received was increased in ECS relative to sham mice (main effect of treatment, p<0.02).
At the test phase (day 29 Fig 3B, S3 Table), there were main effects of group (p<0.03) and
treatment (p<0.04) on total duration of foot shock received; CSS mice received more foot
shock than control mice, and ECS mice received more foot shock than sham mice.
3.4. Pain sensitivity is not altered by CSS or ECS
Pain sensitivity was measured in a subset of mice with the hot plate test (Fig 4, S4 Table). No
significant effects were obtained for either CSS (p = 0.33) or ECS (p = 0.16).
3.5. CSS without effect and ECS increases microglial activity in
hippocampal CA1 and CA3 regions
An Iba-1 staining was conducted to measure microglial activity, which is reflected by the ratio
between percentages of area covered by microglial cell bodies and by total microglial cell size
(cb/c). The cb/c ratio was analysed for the hippocampal areas CA1 and CA3 oriens and radia-
tum, dentate gyrus molecular layer and hilus (Fig 5), and for the prefrontal cortex (PFC) and
the ventral tegmental area (VTA). There were no significant CSS effects (Table 1). Mice that
underwent ECS exhibited an increased cb/c ratio, indicative of increased microglial activity,
for the radiatum of the hippocampal CA1 and CA3 regions specifically (Fig 5; Table 1).
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Fig 2. Effects of CSS and ECS on tone-shock (CS-US) fear conditioning and expression, measured as % time spent freezing. A + B: Fear
conditioning stage; (A) Inter-trial intervals between CS-US pairings, (B) During CS of CS-US trials. C + D: Fear expression stage; (C) Inter-trial intervals
between CS, (D) During CS trials. Data presented as mean + sem. In (A), significant treatment x trial interaction and significant trial-specific treatment
effects in post hoc tests # p<0.05, ### p<0.001. In (B), significant main effect of trial ^ p<0.05, and significant main effect of treatment # p<0.05. In (C) and
(D), significant main effect of treatment #### p<0.0001.
https://doi.org/10.1371/journal.pone.0184603.g002
Fig 3. Total duration of foot shock received in the treadmill fatigue test: (A) habituation phase, (B) test phase. In (A), habituation
comprised 2 min at a speed of 0 cm/sec, 5 min at 15–20 cm/sec at 1 min increments, and 5 min at 20 cm/sec. In (B), the maximum cumulative
duration of foot shock allowed was 10 sec and then the test was terminated; otherwise the maximum test duration was 20 min.
https://doi.org/10.1371/journal.pone.0184603.g003
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3.6. Both CSS and ECS reduce hippocampal cholinergic fiber density
An immunohistochemical staining for choline acetyltransferase (ChAT) was conducted to
quantify cholinergic fiber density in hippocampal areas (Fig 6; Table 2). For each of the CA1
pyramidal layer and CA3 pyramidal layer there was a significant group x treatment interaction
effect (p = 0.03 and p = 0.02, respectively); CSS-sham and control-ECS mice each exhibited
reduced cholinergic fiber density compared to control-sham mice in these regions. For each of
the regions, CA3 oriens, stratum lucidens and radiatum, the molecular layer of the dentate
gyrus and the hilus, there was a significant main effect of treatment, indicating reduced ChAT
signal in ECS relative to sham mice (Table 2).
Fig 4. Hot plate test: latency to first display a pain-related behavior. There was no significant effect of
CSS or ECS.
https://doi.org/10.1371/journal.pone.0184603.g004
Fig 5. Iba-1 immunohistochemistry for the calculation of microglial activity: representative images of
the hippocampal CA1 radiatum, CA3 radiatum and hippocampal hilus regions from control-sham,
control ECS, CSS-sham, CSS-ECS mice.
https://doi.org/10.1371/journal.pone.0184603.g005
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4. Discussion
In the present study design, the exposure of mice to CSS did not induce the expected increase
in fear learning-memory but did induce the expected increase in physical fatigue. ECS
impaired fear learning and memory in CSS and control mice and also increased physical
fatigue in CSS and control mice. CSS was without effect on Iba-1 expression in the hippocam-
pus, while ECS increased Iba-1 expression in hippocampus of CSS and control mice. CSS
decreased hippocampal ChAT expression, and ECS also decreased hippocampal ChAT expres-
sion in CSS and control mice. Therefore, using a mouse model of CSS-induced reactivity to
aversive challenge it was not possible to normalize behavior with ECS and thereby provide
insights into the mechanism of ECT antidepressant function. However, the ECS protocol used
resulted in behavioral effects of anterograde amnesia and fatigue, of direct relevance to the
Table 1. Microglia cell body:total coverage ratio based on Iba-1 immunohistochemistry.
Mean ± sem p-value
CON + sham CSS + sham CON + ECS CSS + ECS Interaction Main effect
Group Treatment
CA1oriens 0.016± 0.003 0.024± 0.004 0.021± 0.004 0.023± 0.003 0.38 0.18 0.47
CA1radiatum 0.018 ± 0.003 0.021± 0.001 0.026± 0.002 0.025± 0.002 0.35 0.65 0.01*
CA3oriens 0.021 ±± 0.002 0.023± 0.002 0.024± 0.002 0.020± 0.002 0.16 0.66 0.86
CA3radiatum 0.017 ± 0.002 0.019± 0.002 0.021± 0.001 0.024± 0.002 0.98 0.17 0.01*
Dentategyrus 0.025 ± 0.003 0.030± 0.003 0.032± 0.002 0.028± 0.002 0.96 0.32 0.28
Hilus 0.032 ± 0.005 0.036± 0.003 0.036± 0.003 0.040± 0.003 0.87 0.28 0.83
PFC 0.030 ± 0.005 0.033± 0.003 0.030± 0.003 0.034± 0.002 0.08 0.87 0.30
VTA 0.010 ± 0.002 0.009± 0.002 0.010± 0.002 0.009± 0.001 0.90 0.76 0.85
PFC = prefrontal cortex; VTA = ventral tegmental area.
Asterisks represent significance
*p<0.05.
https://doi.org/10.1371/journal.pone.0184603.t001
Fig 6. ChAT immunohistochemistry: representative images of the hippocampal CA1, CA3, and
dentate gyrus (DG) regions from control-sham, control ECS, CSS-sham, CSS-ECS mice.
https://doi.org/10.1371/journal.pone.0184603.g006
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observed side effects of ECT in depressed patients, and the associated hippocampal effects of
ECS are of potential relevance in this respect.
Chronic social stress mice exhibited increased daily body weight variability compared with
controls during the 15-day procedure, providing positive biomarker evidence for CSS efficacy
in this study [31–33]. The model of CSS-induced hyper-fear learning and memory was selected
because of its robustness and reproducibility in previous studies (e.g. [35,36]), and because
it would allow for the study of ECS impact in terms of therapeutic-like reversal of increased
aversion reactivity but also side effect-like induction of learning-memory impairment. In the
present study CSS was without effect on Pavlovian fear learning-memory. Compared with
previous studies using the same test conditions (e.g. [33]), CSS-sham mice acquired a lower
amount of freezing during conditioning and expressed less freezing on the following day,
while control-sham mice exhibited freezing levels typical for this condition. In previous studies
this test has been carried out 2–3 days after the 15-day CSS, and in the present study the inter-
val between CSS and testing was 10 days, perhaps indicating that the CSS effect is limited in
terms of its longevity. Another difference between the present study and typical study condi-
tions was that mice underwent isoflurane anaesthesia on each of these intervening days; how-
ever, as noted above, control-sham mice exhibited expected levels of fear learning-memory.
The model of CSS-induced attenuated physical effort on an electrified treadmill was also
selected in relation to its demonstrated robustness [32] and because it would allow for the
study of ECS therapeutic-like reversal induction of fatigue. CSS resulted in the expected deficit
in treadmill running; testing was conducted 14 days after the end of CSS confirming the lon-
gevity of this CSS fatigue effect [35]. CSS was without effect in the hot plate test of pain-sensi-
tivity, as reported previously [32].
The repeated ECS protocol used resulted in reduced learning of the Pavlovian association
between the auditory CS and foot shock US, as demonstrated in both CSS and control mice.
Furthermore, the subsequent expression of the association was, at the statistical level, even
more attenuated by ECS, and again in CSS and control mice. These effects are consistent with
Table 2. Hippocampal cholinergic fibre density based on area covered by ChAT using immunohistochemistry.
Mean ± sem p-value
CON + sham CSS + sham CON + ECS CSS + ECS Interaction Main effect
Group Treatment
CA1oriens 30.31± 1.51 25.32± 2.47 25.40± 0.87 26.14± 1.05 0.07 0.17 0.19
CA1 PL 42.67± 1.50 36.10± 2.51 38.89± 1.24 40.65± 1.18 0.03* 0.41 0.57
CA1radiatum 30.14± 1.56 23.44± 2.21 25.49± 0.84 24.81± 1.24 0.06 0.22 0.10
CA3oriens 41.62± 2.06 33.29± 2.56 33.40± 0.77 33.92± 1.92 0.07 0.49 0.04*
CA3 PL 56.79± 1.82 49.19± 1.91 50.02± 1.00 52.30± 1.41 0.02* 0.45 0.06
CA3 SL 27.47± 2.23 19.89± 3.00 16.07± 1.47 18.78± 1.18 0.23 0.52 <0.001***
CA3radiatum 37.32± 2.30 30.28± 2.74 30.64± 1.03 30.18± 1.63 0.30 0.56 0.02*
Dentategyrus GCL 43.24± 1.44 39.23± 1.70 40.27± 1.13 39.82± 1.01 0.08 0.41 0.06
Dentategyrus ML 28.78± 1.65 25.28± 2.41 24.11± 0.94 23.99± 1.68 0.27 0.63 0.004**
Hilus 29.42± 1.61 25.29± 1.79 23.10± 1.11 22.79± 1.20 0.20 0.30 <0.001***
PL = pyramidal layer; SL = stratum lucidum; GCL = granule cell layer; ML = molecular layer.
Asterisks indicate significance
*p<0.05
**p<0.01
***p<0.001.
P-values are given for the interaction, main effect for treatment (Sham/ECS) and main effect for group (CON/CSS).
https://doi.org/10.1371/journal.pone.0184603.t002
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ECS-induced impaired emotional learning and, in addition, impaired long-term (over-night)
consolidation and/or recall. CS-US learning and memory are mediated primarily in the amyg-
dala [52,53]. ECS-induced deficits in freezing were also observed in the intervals between suc-
cessive CS presentations, both during acquisition and expression; in part these measures are
likely to reflect learning and memory of the association of the general context with foot shock,
and as such impaired function of the hippocampus is also implicated [54]. ECS, in addition to
CSS, increased fatigue in the electrified treadmill test in CSS and CON mice. This ECS effect
was even apparent during the habituation phase of the test, when a relatively low treadmill
speed was applied to allow the mice to become acquainted with the treadmill and acquire the
required operant escape-avoid responses. Therefore, it is possible that ECS impaired the oper-
ant active avoidance learning that is essential for adaptive behavior in the treadmill test. The
CSS effect, and possibly to some extent also the ECS effect, is consistent with reduction in the
level of effort mice were able/motivated to exert to avoid-escape foot shock [32]. A similar
effect was induced by pharmacological depletion of dopamine in the nucleus accumbens [34].
CSS was without effect in the hot plate test of pain-sensitivity.
Therefore, the present data demonstrate that the repeated ECS protocol used induces anter-
ograde learning and memory deficits. Several previous studies have reported ECS-induced
learning and memory deficits in rodents [55–58]. Cognitive impairment, particularly antero-
grade and retrograde amnesia, is one of the most common side effects of ECT (for reviews, see
[5,59]). The mechanisms underlying ECT-induced memory deficits are currently unknown,
but structural and functional alterations in the cholinergic system have been proposed to be
involved [40,41]. In line with this hypothesis, the current study provides evidence for choliner-
gic abnormalities after ECS in multiple hippocampal regions. The cholinergic system is essen-
tial for adaptive learning and memory, and thus the ECS-related cognitive deficits observed in
this study may well be related to the co-occurring changes in ChAT-based cholinergic fiber
density. Indeed, a recent study demonstrated that ECS-induced memory disturbances in
rodents could be prevented by the cholinesterase inhibitor physostigmine and by the α4β2 nic-
otinic acetylcholine receptor (nAchR) agonist ABT-418, but not by the α7 nAchR agonist ana-
basine [41]. Further evidence for α4 nAchR involvement is provided by the finding that ECS
reduces its expression in rodent prefrontal cortex and hippocampus [41]. With respect to
human ECT, the cholinergic system and memory deficits, it has been reported that the acetyl-
cholinesterase inhibitor rivastigmine enhanced memory in ECT-treated schizophrenia
patients [40]. Together, these findings support the hypothesis that reduced synaptic signalling
in the cholinergic system constitutes an important component of the ECS- and ECT-induced
CNS changes underlying the major side-effect of cognitive impairment. Short and long-term
rearrangement of connections from the hippocampus to frontotemporal connections and the
amygdala are considered underlying mechanisms [19,20], which might also be the cause of
severe memory problems that are sometimes observed during the course of ECT. The potential
prevention of cognitive side effects by manipulations of the cholinergic system such as co-
treatment with acetylcholinesterase inhibitors and acetylcholine receptor agonists in the
CSSxECS paradigm applied in the current study would be an interesting direction for future
research.
In addition to ECS effects in terms of reduced hippocampal ChAT expression, CSS led to
reduced ChAT expression in the CA1 and CA3 pyramidal regions of sham mice specifically.
These findings add to the existing evidence for abnormal central cholinergic functioning in
chronic stress models, in the form of altered acetylcholinesterase levels and activity [60–65].
Indeed, it has been suggested that cholinergic deficits play an important role in stress-induced
cognitive deficits [66].
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Altered Iba-1 expression consistent with increased microglial activity was also observed in
hippocampus of ECS mice, albeit in the radiatum of CA1 and CA3 regions, which did not
exhibit cholinergic changes. There was no effect of ECS on Iba-1 expression in other hippo-
campal sub-regions, or in the prefrontal cortex or ventral tegmental area. Several previous
studies have investigated ECS effects on microglial activity and findings are somewhat incon-
sistent [6,42,67–69]. Immune system activation is proposed to lead to temporary cognitive def-
icits including memory impairment, mediated by the hippocampus (for review, see [43]).
Therefore, increased microglial activity might contribute causally to the cognitive side effects
of ECT Furthermore, given that cholinergic signalling is influenced by anti-inflammatory
actions [70], microglial activation might contribute to ECS-induced cholinergic modifications.
However, it is important to note that immune system activation might also be important in the
mediation of the therapeutic effects of ECT [71].
It is important to realize that additional mechanisms might be involved in the induction of
cognitive deficits by ECT. For example, it has been suggested that ECT sessions result in satu-
ration of long-term potentiation (LTP), a process mediated by activation of glutamatergic
NMDA receptors, thereby reducing capacity for further neuroplasticity necessary for memory
formation. In addition, ECS is known to be a strong inducer of neurogenesis [12,13]., and it
has recently been suggested that excessive neurogenesis might decrease memory retention by
interfering with existing synaptic connections [72].
The view that hippocampal LTP and plasticity are involved in the mediation of ECT-
induced cognitive dysfunction is supported by rodent studies demonstrating impaired induc-
tion of LTP after repeated ECS, combined with evidence that ECS itself increases LTP [73–75].
In addition, LTP could be prevented in rodents by anesthesia with the NMDA receptor antag-
onist ketamine during ECS sessions [74,76,77]. Human studies confirm a positive effect of
ketamine on ECT-induced cognitive side effects [78–80]. It would be highly interesting to
study the effects of ketamine anesthesia during ECS sessions on LTP and cognition in the
CSSxECS paradigm.
5. Limitations
Several limitations should be kept in mind. First, the primary aim of developing a model in
which depression-relevant behavioral changes are reversed by ECS could not be achieved This
was in part because the combination of CSS and repeated anaesthesia resulted in a loss of the
usual CSS effect of increased fear learning-memory, and in part because ECS failed to normal-
ize increased fatigue. This is in contrast to studies in which it has been demonstrated that the
CSS-induced increase in fear memory is reversed by repeated administration of escitalopram
[33] and the CSS-induced decrease in operant behavior for reward is partly reversed by agome-
latine [34]. In addition, as our primary goal was to study reversal of depression-like behavior
instead of cognitive deficits, we did not incorporate an extensive test battery for cognitive func-
tion. Our evidence for cognitive dysfunction is mainly derived from the fear learning-memory
paradigm, in combination with the observation that ECS mice failed to show normal habitua-
tion to the treadmill fatigue test, an effect that is likely related to impaired learning. In future
studies, tests for other types of memory, such as spatial memory and episodic memory, should
also be included. Furthermore, the ECS protocol applied in this study varies on several points
from a clinical ECT protocol. For example, isoflurane anesthesia, though common in ECS
experiments, is not commonly used for clinical ECT procedures. Instead the use of injection
anesthetics such as propofol or methohexital is preferred in a clinical setting. Administration
of injection anesthetics in mice however poses practical challenges and may induce stress,
which itself could influence subsequent behavioral and immunohistochemical read-out
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parameters. The same applies to the use of muscle relaxants, which are commonly used in clin-
ical practice but not in animal experiments because of practical challenges posed by the need
for ventilation.
In addition, ECT is typically given 2–3 times per week and current dose is titrated to ensure
that the minimal dose necessary to achieve a seizure of sufficient intensity is used. In the cur-
rent study mice underwent ECS on a daily basis for 10 days and fixed stimulus parameters
were used. It has been suggested that higher stimulus intensity may be associated with
increased severity of cognitive side effects [81]. However, our understanding of how cognitive
side effects are influenced by different stimulus parameters and treatment schedules remains
limited. Dose-response experiments including different ECS stimulus parameters and treat-
ment schedules in combination with behavioral assessment of cognition would be invaluable
for increasing our understanding of the relation between treatment parameters and cognitive
side effects.
Despite these limitations this study provides valuable insights into the cognitive side effects
of ECS and mechanisms underlying these effects.
6. Conclusion
The primary aim of this study was to establish a model of ECS reversal of depression-relevant,
stress-induced behavior, thereby allowing for the study of brain changes underlying ECT in
human depression. Stress-induced excessive fear learning-memory did not survive the ECS
protocol. Stress-induced fatigue was not reversed by the ECS protocol. A secondary, important
aim was to investigate whether ECS induces side-effects similar to those commonly reported
for ECT in depressed patients. Indeed, the repeated ECS protocol led to marked anterograde
impairment in learning and memory and increased fatigue, both in CSS and control mice.
These behavioral deficits co-occurred with decreased hippocampal ChAT activity and
increased hippocampal microglial activity. These same changes might contribute to the patho-
physiology underlying the important side effects that need to be better understood and man-
aged in the application of ECT to patients with treatment-resistant depression.
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